+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Precision Diagnostics & Medicine Market by Product (Consumables, Instruments), Technology (Genomics, Molecular Diagnostics, Proteomics), Application, End User - Global Forecast 2025-2030- Product Image
Precision Diagnostics & Medicine Market by Product (Consumables, Instruments), Technology (Genomics, Molecular Diagnostics, Proteomics), Application, End User - Global Forecast 2025-2030- Product Image
Sale

Precision Diagnostics & Medicine Market by Product (Consumables, Instruments), Technology (Genomics, Molecular Diagnostics, Proteomics), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055133
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Precision Diagnostics & Medicine Market grew from USD 160.21 billion in 2024 to USD 176.82 billion in 2025. It is expected to continue growing at a CAGR of 11.00%, reaching USD 299.71 billion by 2030.

In the rapidly evolving sector of precision diagnostics and medicine, groundbreaking innovations and shifting market dynamics are redefining healthcare solutions. The past decade has witnessed a convergence of advanced technologies, novel research paradigms, and tailored therapeutic strategies - all of which have contributed to more effective patient care and improved clinical outcomes. This report takes a deep dive into the dynamic interplay between emerging technologies, product offerings, and regulatory influences that collectively steer the market's direction. It highlights the growing significance of accurate diagnostics and personalized treatments, which are now at the forefront of the medical industry.

In this comprehensive study, we explore the vital trends reshaping the future of healthcare. By presenting a detailed overview of market segmentation, technological advancements, and geographic expansions, the insights provided here empower both experts and decision-makers. Our analysis underscores the critical balance between innovative research and practical applications, ensuring that each stakeholder finds actionable strategies to succeed in this competitive environment. The report is designed to serve as a guiding tool, sparking informed investment decisions and paving the way for future advancements in precision medicine.

Transformative Shifts in the Market Landscape

The landscape of precision diagnostics and medicine has experienced transformative shifts, driven by technological breakthroughs and evolving consumer needs. Rapid advancements in genomics, molecular diagnostics, and proteomics have significantly altered traditional paradigms, pushing the envelope of what is possible in patient care and data analytics. As market players adapt to newer methodologies and innovative product offerings, there is a visible reallocation of resources geared toward enhancing accuracy, reducing time to diagnosis, and improving overall patient management.

Industry trends indicate a movement away from conventional diagnostic methods towards integrated, high-throughput systems and digitally enabled solutions. This shift is further fortified by the need for personalized medicine, where treatments are tailored to individual genetic, environmental, and lifestyle factors. Collaborative partnerships among research institutions, industry leaders, and regulatory bodies have accelerated progress in streamlined diagnostics and targeted therapies. The collective momentum is not only reshaping clinical landscapes but also inviting novel business models that emphasize agility, scalability, and continuous innovation.

Such developments continue to redefine strategic planning and investment decisions as organizations prepare to navigate the complexities of evolving market demands.

Key Segmentation Insights Shaping Market Dynamics

Deep insights into market segmentation reveal critical layers that shape competitive and strategic decisions within the precision diagnostics and medicine sector. The analysis begins with product-based segmentation, where the market is categorized into consumables and instruments. Within consumables, further investigation identifies kits and assays alongside reagents as key drivers, while instruments are examined through the lens of analyzers, imaging systems, and sequencers. This layered approach reflects the diverse nature of products that serve multiple clinical and laboratory applications.

Technology-based segmentation further dissects the market into distinct areas that include genomics, molecular diagnostics, and proteomics. Special emphasis is placed on molecular diagnostics, where the capabilities of next-generation sequencing are compared with those of polymerase chain reaction techniques. Meanwhile, application-based segmentation sheds light on how diagnostic innovations are utilized across various domains such as disease diagnosis, precision therapeutics, and research and development. Notably, disease diagnosis delves into chronic diseases and genetic disorders, and precision therapeutics is refined even further into personalized medicine and targeted therapies.

The segmentation based on end users also contributes significantly, highlighting roles played by clinical laboratories and hospitals, with clinical laboratories further bifurcated into diagnostic and research laboratories. Each segmentation dimension offers nuanced insights into market trends, empowering industry stakeholders to prioritize investments and foster innovation in areas that promise maximum impact.

Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Kits & Assays and Reagents. The Instruments is further studied across Analyzers, Imaging Systems, and Sequencers.

Based on Technology, market is studied across Genomics, Molecular Diagnostics, and Proteomics. The Molecular Diagnostics is further studied across Next-Generation Sequencing and Polymerase Chain Reaction.

Based on Application, market is studied across Disease Diagnosis, Precision Therapeutics, and Research & Development. The Disease Diagnosis is further studied across Chronic Diseases and Genetic Disorders. The Precision Therapeutics is further studied across Personalized Medicine and Targeted Therapies.

Based on End User, market is studied across Clinical Laboratories and Hospitals. The Clinical Laboratories is further studied across Diagnostic Laboratories and Research Laboratories.

In-Depth Regional Insights Across Global Markets

The market’s evolution is uniquely influenced by regional dynamics that vary based on geographic, economic, and regulatory environments. In the Americas, robust healthcare infrastructures combined with substantial research investments have accelerated the pace of innovation in precision diagnostics and medicine. Economic stability and supportive policy frameworks provide an attractive ecosystem for research and development initiatives, while growing awareness about early disease detection continues to fuel market expansion.

In the combined regions of Europe, the Middle East, and Africa, traditional medicine practices intersect with modern diagnostic techniques, establishing a transitional landscape where regulatory harmonization and advanced technology adoption are gaining momentum. Multiple nations are actively investing in healthcare technology upgrades, aligning themselves with global standards while also addressing local health challenges through customized solutions. Conversely, the Asia-Pacific region is emerging as a vibrant hub for medical research and technology-driven healthcare solutions, buoyed by rapid economic growth and increasing patient demands. This region’s dynamic mix of public and private sector initiatives, paired with aggressive digitization strategies, positions it at the forefront of groundbreaking diagnostic methodologies.

Understanding these regional insights is crucial for stakeholders aiming to develop localized strategies that cater to diverse market needs while simultaneously capitalizing on global trends.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Competitive Landscape and Key Company Insights

The competitive arena within precision diagnostics and medicine is marked by a host of influential companies that drive innovation and set industry standards. Leading multinational corporations have consistently demonstrated the ability to adapt and excel through rigorous research and strategic collaborations. Prominent industry players include Abbott Laboratories, AstraZeneca PLC, Baxter International Inc., and Becton, Dickinson and Company, each contributing uniquely to advancements in diagnostic tools and therapeutic solutions.

Additional key companies such as Biogen Inc., Bristol-Myers Squibb Company, Danaher Corporation, and F. Hoffmann-La Roche Ltd have bolstered their positions through significant investments in research, facilitating the development of state-of-the-art diagnostic instruments and consumables. Enterprises including GE Healthcare Technologies, Illumina, Inc., and International Business Machines Corp. continue to integrate cutting-edge technologies into their product portfolios, further enhancing data accuracy and operational efficiency. The competitive landscape is further enriched by the strategic efforts of Johnson & Johnson Services, Koninklijke Philips N.V., Lantheus Medical Imaging, Inc., and Medtronic PLC, whose robust market presence and innovation pipelines distinguish them as market leaders.

Additional contributions from Myriad Genetics Inc., Novartis AG, OneOme, LLC, Pfizer Inc., Qiagen NV, Quest Diagnostics Incorporated, Sanofi S.A., Siemens Healthineers, Swiss Precision Diagnostics GmbH, and Thermo Fisher Scientific Inc. serve not only to intensify market competition but also to drive continuous improvements in product quality, regulatory compliance, and patient care outcomes. Such a diverse yet competitive sector elevates the importance of dynamic strategic planning and adaptability in the face of ongoing industry evolution.

The report delves into recent significant developments in the Precision Diagnostics & Medicine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca PLC, Baxter International Inc., Becton, Dickinson and Company, Biogen Inc., Bristol-Myers Squibb Company, Danaher Corporation, F. Hoffmann-La Roche Ltd, GE Healthcare Technologies, Inc., Illumina, Inc., International Business Machines Corp., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lantheus Medical Imaging, Inc., Medtronic PLC, Myriad Genetics Inc., Novartis AG, OneOme, LLC, Pfizer Inc., Qiagen NV, Quest Diagnostics Incorporated, Sanofi S.A., Siemens Healthineers, Swiss Precision Diagnostics GmbH, and Thermo Fisher Scientific Inc..

Actionable Recommendations for Industry Leaders to Innovate and Grow

Industry leaders can harness emerging opportunities in the precision diagnostics and medicine space by actively aligning their business strategies with evolving market realities. A primary recommendation is to invest in research and development initiatives that target high-potential segments identified through detailed market analysis. Emphasizing the integration of advanced technologies such as next-generation sequencing and high-throughput analyzers will not only enhance diagnostic accuracy but also streamline the operational efficiency of clinical and research laboratories.

Leaders are encouraged to cultivate strategic partnerships with technology innovators, academic institutions, and regulatory agencies to develop comprehensive solutions that cater to increasingly sophisticated market demands. An approach that balances agility with robust quality control measures can facilitate the timely adoption of breakthrough diagnostics, particularly in rapidly evolving domains such as personalized medicine and targeted therapeutics. It is also critical to maintain a flexible approach to product development cycles, allowing for timely iterations in response to emerging trends and consumer preferences.

Furthermore, aligning market strategies with regional insights can amplify competitive advantages by addressing localized challenges and capitalizing on specific demographic opportunities. Recognizing the importance of digital transformation initiatives, firms should integrate data analytics, artificial intelligence, and cloud-based solutions into their operational frameworks. Such proactive measures will enable companies to not only stay ahead of the curve but also set new benchmarks in patient care and industry innovation.

The exploration of the precision diagnostics and medicine market reveals an intricate mosaic driven by transformative technologies, strategic segmentation, and robust regional influences. The convergence of product innovations, technological advancements, and targeted applications highlights the multifaceted nature of the industry. As companies navigate through evolving consumer expectations, regulatory challenges, and competitive pressures, there is an overarching emphasis on personalized solutions that are responsive to both clinical needs and research advancements.

A thorough examination of segmentation shows that differentiating products into consumables and instruments, integrating genomics, molecular diagnostics, and proteomics across various applications, and understanding user-specific demands are pivotal in staying competitive. Similarly, regional insights illustrate that market dynamics vary significantly based on geographic and economic contexts, necessitating tailored strategies for effective market penetration. The analysis underlines that success in this sector hinges on agile innovation, strategic partnerships, and a deep commitment to advancing patient care.

In conclusion, the journey toward sustainable growth in precision diagnostics and medicine is anchored in the continuous evolution of technology and market responsiveness. Stakeholders equipped with relevant market intelligence and proactive strategies will be well-positioned to drive future advancements and set industry standards for excellence.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of chronic diseases globally
5.1.1.2. Increasing demand for personalized healthcare solutions worldwide
5.1.1.3. Government initiatives promoting precision diagnostics worldwide
5.1.2. Restraints
5.1.2.1. Stringent regulatory compliance requirements in precision diagnostics and personalized treatment
5.1.3. Opportunities
5.1.3.1. Surge in biopharmaceutical research supporting biomarker discovery and validation techniques
5.1.3.2. Advancements in genomic technologies enabling personalized treatment plans
5.1.4. Challenges
5.1.4.1. Issues in integrating precision diagnostic techniques into legacy healthcare systems
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing preference for kits & assays for precise disease detection and monitoring
5.2.2. Application: Expanding application of precision diagnostics and medicine in precision therapeutics
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Precision Diagnostics & Medicine Market, by Product
6.1. Introduction
6.2. Consumables
6.2.1. Kits & Assays
6.2.2. Reagents
6.3. Instruments
6.3.1. Analyzers
6.3.2. Imaging Systems
6.3.3. Sequencers
7. Precision Diagnostics & Medicine Market, by Technology
7.1. Introduction
7.2. Genomics
7.3. Molecular Diagnostics
7.3.1. Next-Generation Sequencing
7.3.2. Polymerase Chain Reaction
7.4. Proteomics
8. Precision Diagnostics & Medicine Market, by Application
8.1. Introduction
8.2. Disease Diagnosis
8.2.1. Chronic Diseases
8.2.2. Genetic Disorders
8.3. Precision Therapeutics
8.3.1. Personalized Medicine
8.3.2. Targeted Therapies
8.4. Research & Development
9. Precision Diagnostics & Medicine Market, by End User
9.1. Introduction
9.2. Clinical Laboratories
9.2.1. Diagnostic Laboratories
9.2.2. Research Laboratories
9.3. Hospitals
10. Americas Precision Diagnostics & Medicine Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Precision Diagnostics & Medicine Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Precision Diagnostics & Medicine Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2024
13.2. FPNV Positioning Matrix, 2024
13.3. Competitive Scenario Analysis
13.3.1. Precision Diagnostics announces the launch of VerifID, a solution that redefines sample authentication
13.3.2. Aignostics accelerates precision diagnostics with a USD 34 million Series B funding for AI-driven pathology
13.3.3. Danaher Corporation announced the launch of two new CLIA and CAP-certified labs
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. PRECISION DIAGNOSTICS & MEDICINE MARKET MULTI-CURRENCY
FIGURE 2. PRECISION DIAGNOSTICS & MEDICINE MARKET MULTI-LANGUAGE
FIGURE 3. PRECISION DIAGNOSTICS & MEDICINE MARKET RESEARCH PROCESS
FIGURE 4. PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 9. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 11. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 13. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 15. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 17. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 19. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. PRECISION DIAGNOSTICS & MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 25. PRECISION DIAGNOSTICS & MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. PRECISION DIAGNOSTICS & MEDICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. PRECISION DIAGNOSTICS & MEDICINE MARKET DYNAMICS
TABLE 7. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TARGETED THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 71. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 73. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 74. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 76. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 78. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 79. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 81. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 83. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 84. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 86. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 88. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 89. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 123. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 125. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 126. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 128. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 130. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 131. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 133. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 135. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 136. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 138. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 140. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 141. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 143. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 153. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 155. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 156. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 158. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 160. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 161. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 163. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 165. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 166. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 168. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 170. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 171. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 173. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 175. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 180. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 183. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 185. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 186. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 188. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 190. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 191. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 193. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 203. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 205. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 206. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 208. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 210. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 211. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 213. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 215. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 216. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 218. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 220. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 221. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 223. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 224. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 244. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 245. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 246. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 247. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 248. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 249. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 251. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 252. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 254. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 255. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 256. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 257. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 259. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 261. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 262. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 264. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 265. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 266. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 267. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 268. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 269. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 271. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 272. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 274. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 275. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 276. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 277. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 278. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 279. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 281. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 282. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 284. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 285. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 286. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 287. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 288. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 289. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 291. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 292. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 294. ISRAEL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 296. ISRAEL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 297. ISRAEL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 298. ISRAEL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 301. ISRAEL PRECISION DI

Companies Mentioned

  • Abbott Laboratories
  • AstraZeneca PLC
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Biogen Inc.
  • Bristol-Myers Squibb Company
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare Technologies, Inc.
  • Illumina, Inc.
  • International Business Machines Corp.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.
  • Lantheus Medical Imaging, Inc.
  • Medtronic PLC
  • Myriad Genetics Inc.
  • Novartis AG
  • OneOme, LLC
  • Pfizer Inc.
  • Qiagen NV
  • Quest Diagnostics Incorporated
  • Sanofi S.A.
  • Siemens Healthineers
  • Swiss Precision Diagnostics GmbH
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages196
PublishedMarch 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 176.82 Billion
Forecasted Market Value ( USD ) by 2030 $ 299.71 Billion
Compound Annual Growth Rate11.0%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Cancer Diagnostics Market by Diagnostic Type, Indication, Components, End-Use - Global Forecast 2025-2030 - Product Image

Cancer Diagnostics Market by Diagnostic Type, Indication, Components, End-Use - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Diagnostic Collaboration and Licensing Deals 2020-2024 - Product Image

Diagnostic Collaboration and Licensing Deals 2020-2024

  • Report
  • 750 Pages
  • Global
From
Cancer Diagnostic Collaboration and Licensing Deals 2018-2024 - Product Image

Cancer Diagnostic Collaboration and Licensing Deals 2018-2024

  • Report
  • 450 Pages
  • Global
From
Dental Diagnostic & Surgical Equipment Market by Type, Treatment, End-User - Global Forecast 2025-2030 - Product Image

Dental Diagnostic & Surgical Equipment Market by Type, Treatment, End-User - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis Report By Test (Immunoglobulin Diagnostic Tests), By Technology, By Application, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis Report By Test (Immunoglobulin Diagnostic Tests), By Technology, By Application, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.